Newsfeeds Archive - Spark Newswire

2 minute read

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

May 17, 11:02 AM

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

ALPMF

1 minute read

Merck’s Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study

By Vandana Singh

October 5, 9:35 AM

Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual primary endpoints of disease-free survival for the adjuvant treatment of localized muscle-invasive urothelial carcinoma and

ALPMF

1 minute read

Why Is Seagen Stock Trading Higher Today?

By Vandana Singh

September 22, 11:05 AM

Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC:

ALPMF

1 minute read

What’s Going On With Neurology Focused Taysha Gene Therapies Stock Today?

By Vandana Singh

September 20, 2:12 PM

Astellas Pharma Inc (OTC: ALPMY) (OTC: ALPMF) has elected

ALPMF

1 minute read

Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles

By Vandana Singh

June 8, 12:10 PM

Astellas Pharma Inc (OTC: ALPMF) (OTC: ALPMY) decided to license and advance a gene therapy from Kate Therapeutics for a debilitating muscle disorder known as

ALPMF

5 minute read

Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today’s Top Stories

By Vandana Singh

May 15, 9:47 AM

Bloomberg

AAPL

2 minute read

Astellas’ Menopause Drug Sores FDA Approval, After Regulatory Setback

By Vandana Singh

May 15, 6:57 AM

The FDA on Friday approved Japanese drugmaker Astellas Pharma Inc’s (OTC: ALPMY) (OTC: ALPMF) Veozah (fezolinetant) for hot flashes

ALPMF

1 minute read

Pfizer, Astellas’ Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%

By Vandana Singh

May 1, 2:32 PM

Astellas Pharma Inc (OTC: ALPMY) and Pfizer Inc (NYSE: PFE) announced

ALPMF

1 minute read

Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On ‘Blindness & Regeneration’

By Vandana Singh

May 1, 8:00 AM

Japanese healthcare company Astellas Pharma Inc (OTC: ALPMY) has agreed to buy Iveric Bio Inc (NASDAQ: ISEE) for $40.00 per share in cash for a total equity value of

ALPMF

1 minute read

FDA Approves Merck’s Keytruda Combined With Seagen/Astellas’s Padcev For Advanced Urothelial Cancer

By Vandana Singh

April 4, 9:08 AM

The FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with Astellas Pharma Inc (OTC:ALMPF) & Seagen Inc’s (NASDAQ:SGEN) Padcev (enfortumab vedotin-ejfv) locally…

ALMPF